1. National Cancer Information Center. Cancer fact and figures 2012 in the Republic of Korea [Internet] Goyang: National Cancer Center. 2014;cited 2015 Apr 25. Available from:
http://www.cancer.go.kr/mbs/cancer/index.jsp
2. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998-2005.
3. Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med 2014;174:448-454.
4. Cho BL. Evaluation of the validity of current national health screening program and plan to improve the system. Cheongwon: Korea Centers for Disease Control & Prevention; 2012.
5. Fitzpatrick-Lewis D, Hodgson N, Ciliska D, Peirson L, Gauld M, Liu YY. Breast cancer screening. Calgary: Canadian Task Force on Preventive Health Care; 2011.
7. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6:CD001877.
8. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006;368:2053-2060.
10. Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Salander H, Save-Soderbergh J, Wahlin T. The Gothenburg Breast Screening Trial. Cancer 2003;97:2387-2396.
11. Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst 1986;77:317-320.
13. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Followup after 11 years-update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45:263-270.
14. Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260:658-663.
17. Kim JY, Cho BH, Hur MH, Kang SS, Lee JH, Lee SK, Cho BJ, Lee KS, Lee HK. Interval breast cancers: comparisons with screen detected cancers. J Korean Surg Soc 2002;63:458-461.
18. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007;146:502-510.
19. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positivemammograms on generic and specific psychosocial outcomes. Psychooncology 2010;19:1026-1034.
21. Beckett JR, Kotre CJ, Michaelson JS. Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme. Br J Radiol 2003;76:309-320.
24. Salas D, Ibanez J, Roman R, Cuevas D, Sala M, Ascunce N, Zubizarreta R, Castells X. CFPR (Cumulative False Positive Risk) group. Effect of start age of breast cancer screening mammography on the risk of false-positive results. Prev Med 2011;53:76-81.
27. Hur MH, Cho BH, Lee HK, Kang SS, Lee KS, Cho BJ, Gu JS, Yoon SO, Lee SK, Lee JH. Breast cancer screening of 51,170 women. J Korean Surg Soc 2002;63:11-17.
28. Utzon-Frank N, Vejborg I, von Euler-Chelpin M, Lynge E. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark. Cancer Epidemiology 2011;35:393-398.
29. Otten JD, Fracheboud J, den Heeten GJ, Otto SJ, Holland R, de Koning HJ, Broeders MJ, Verbeek AL. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study. Ann Oncol 2013;24:2501-2506.
30. Tohno E, Umemoto T, Sasaki K, Morishima I, Ueno E. Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. Eur J Radiol 2013;82:1227-1230.
32. Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology 2012;265:59-69.
33. Girardi V, Tonegutti M, Ciatto S, Bonetti F. Breast ultrasound in 22,131 asymptomatic women with negative mammography. Breast 2013;22:806-809.
34. Moon HJ, Jung I, Park SJ, Kim MJ, Youk JH, Kim EK. Comparison of cancer yields and diagnostic performance of screening mammography vs. supplemental screening ultrasound in 4394 women with average risk for breast cancer. Ultraschall Med 2014;04. 24. [Epub].
http://dx.doi.org/10.1055/s-0034-1366288
35. Chang JM, Koo HR, Moon WK. Radiologist-performed hand-held ultrasound screening at average risk of breast cancer: results from a single health screening center. Acta Radiol 2014;06. 20. [Epub].
http://dx.doi.org/10.1177/0284185114538252
36. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology 2001;221:641-649.
37. Kwak JY, Kim EK, Jung HK, Park HL, Kwon TH. The usefulness of additional bilateral whole breast US with negative mammographic results in asymptomatic women. J Korean Radiol Soc 2005;53:451-456.
39. Corsetti V, Houssami N, Ferrari A, Ghirardi M, Bellarosa S, Angelini O, Bani C, Sardo P, Remida G, Galligioni E, Ciatto S. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer 2008;44:539-544.
40. Giuliano V, Giuliano C. Improved breast cancer detection in asymptomatic women using 3D-automated breast ultrasound in mammographically dense breasts. Clin Imaging 2013;37:480-486.
41. Pisani P, Parkin DM, Ngelangel C, Esteban D, Gibson L, Munson M, Reyes MG, Laudico A. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006;118:149-154.
42. Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R, Miller AB, Daniel EE, Gupta S, Uplap P, Thakur MH, Ramani S, Kerkar R, Ganesh B, Shastri SS. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010;126:976-984.
43. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, Venugopal M, Anju G, Mathew BS. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011;103:1476-1480.
44. Miller AB. Practical applications for Clinical Breast Examination (CBE) and Breast Self-Examination (BSE) in screening and early detection of breast cancer. Breast Care (Basel) 2008;3:17-20.
45. Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst 1986;77:317-320.
46. Suzuki A, Kuriyama S, Kawai M, Amari M, Takeda M, Ishida T, Ohnuki K, Nishino Y, Tsuji I, Shibuya D, Ohuchi N. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry. Cancer Sci 2008;99:2264-2267.
47. Chiarelli AM, Majpruz V, Brown P, Theriault M, Shumak R, Mai V. The contribution of clinical breast examination to the accuracy of breast screening. J Natl Cancer Inst 2009;101:1236-1243.
48. Oestreicher N, Lehman CD, Seger DJ, Buist DS, White E. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR Am J Roentgenol 2005;184:428-432.
49. Ohta K, Kasahara Y, Tanaka F, Maeda H. Is clinical breast examination effective in Japan? Consideration from the age-specific performance of breast cancer screening combining mammography with clinical breast examination Breast Cancer 2014;06. 13. [Epub].
http://dx.doi.org/10.1007/s12282-014-0544-0